Strategic partnerships Paragonix actively engages with organ donation networks and clinical organizations (Donor Network West, ISHLT, CHEST Lung Donation Workshop) to expand adoption of its KidneyVault and lung preservation technologies, presenting ongoing sales opportunities through collaboration and access expansion.

Clinical evidence Recent ISHLT presentations and real-world data initiatives with caresyntax indicate a strong emphasis on evidence-based outcomes, creating chances to position Paragonix as a preferred solution for hospitals seeking proven organ preservation performance.

Expansion potential With a growing footprint in organ transport and preservation, Paragonix is pursuing nationwide access programs and clinical support initiatives, suggesting scalable opportunities to expand in hospital networks and regional procurement organizations.

Technology integration Utilizing a modern tech stack and data partnerships, Paragonix can be positioned to benefit from integrated procurement workflows, BigQuery analytics, and digital marketing/CRM support to drive sales outreach and customer onboarding.

Market positioning Revenue in the mid-range tens of millions and a specialized focus on hypothermic preservation and perfusion systems align Paragonix with high-value, high-need organ transplant programs, presenting targeted upsell and cross-sell opportunities to existing customers and partners.